Toxic epidermal necrolysis versus cutaneous Graft-Versus-Host Disease in a hematopoietic stem cell transplant recipient: the role of elafin

Leuk Lymphoma. 2018 Sep;59(9):2261-2263. doi: 10.1080/10428194.2017.1422867. Epub 2018 Jan 11.

Authors

Alessandra Chen¹, Kevin Chao¹, Lina Rodriguez², William Munday³, Scott Worswick^{1

2}

Affiliations

¹ a David Geffen School of Medicine at UCLA , Los Angeles , CA , USA.
² b Department of Medicine, Division of Dermatology , University of California , Los Angeles , CA , USA.
³ c Department of Pathology , University of California , Los Angeles , CA , USA.

PMID: 29322835
DOI: 10.1080/10428194.2017.1422867

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Biomarkers / analysis*
Diagnosis, Differential
Elafin / analysis*
Graft vs Host Disease / diagnosis*
Graft vs Host Disease / etiology
Graft vs Host Disease / metabolism
Hematopoietic Stem Cell Transplantation / adverse effects
Hematopoietic Stem Cell Transplantation / methods*
Humans
Male
Skin / pathology*
Stevens-Johnson Syndrome / diagnosis*
Stevens-Johnson Syndrome / etiology
Stevens-Johnson Syndrome / metabolism

Substances

Biomarkers
Elafin